Table 1 Demographic characteristics of the 59,800 pregnancies examined by NIPT.
Characteristic | NIPT | Expanded NIPT | p |
|---|---|---|---|
Total | 48,018(100.00%) | 11,782 (100.00%) | Ā |
Mean age when performed NIPT (SD), years | 30.2ā±ā12.5 | 30.1ā±ā10.8 | 0.08 |
Gestational age at NIPT | |||
Ā 12ā~ā19+ā6 weeks | 27,975(58.26%) | 9091(77.16%) | 7.5549E-314 |
Ā 20ā~ā23+ā6 weeks | 11,909(24.80%) | 1332(11.31%) | 2.2797E-219 |
Ā 24ā~ā29+ā6 weeks | 6002(12.50%) | 1141(9.68%) | 3.08855E-17 |
Ā 30ā~ā34+ā6 weeks | 2022(4.21%) | 210(1.78%) | 1.2109E-35 |
Ā ā„ā35 weeks | 110(0.23%) | 8(0.23%) | 0.000411271 |
Serological screening for high or intermediate risks | 22,160(46.15%) | 6074(51.55%) | 6.37874E-26 |
Serological screening for the single marker value abnormality(AFP, β-HCG, uE3) | 14,790(30.80%) | 1071(9.09%) | 0 |
Ultrasound soft marker abnormalities | 4634(9.65%) | 2724(23.12%) | 0 |
isolated advanced maternal age (ā„ā35 years, AMA) | 6170(12.85%) | 1439(12.21% | 0.06348737 |
Other typesa | 264(0.55%) | 474(4.03%) | 1.2245E-205 |
IVF pregnancies | 2900 (6.04%) | 1120 (9.51%) | 2.50238E-41 |
Fetal fragment fraction | 15.78%(4.10-35.65%) | 17.81%(7-36.807%) | Ā |